Next Article in Journal
Impact of Polypharmacy on Candidate Biomarker miRNomes for the Diagnosis of Fibromyalgia and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Striking Back on Treatments
Next Article in Special Issue
Challenges and Recent Progress in Oral Drug Delivery Systems for Biopharmaceuticals
Previous Article in Journal / Special Issue
What Drives Innovation: The Canadian Touch on Liposomal Therapeutics
 
 
Review

Article Versions Notes

Pharmaceutics 2019, 11(3), 125; https://doi.org/10.3390/pharmaceutics11030125
Action Date Notes Link
article xml file uploaded 16 March 2019 06:57 CET Original file -
article xml uploaded. 16 March 2019 06:57 CET Update https://www.mdpi.com/1999-4923/11/3/125/xml
article pdf uploaded. 16 March 2019 06:57 CET Version of Record https://www.mdpi.com/1999-4923/11/3/125/pdf
article html file updated 16 March 2019 06:58 CET Original file -
article html file updated 2 April 2019 04:47 CEST Update -
article html file updated 4 April 2019 14:25 CEST Update -
article html file updated 11 April 2019 21:21 CEST Update -
article html file updated 26 April 2019 02:21 CEST Update -
article html file updated 16 October 2019 16:58 CEST Update -
article html file updated 11 February 2020 22:38 CET Update -
article html file updated 19 July 2022 16:27 CEST Update https://www.mdpi.com/1999-4923/11/3/125/html
Back to TopTop